Cargando…
Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab
The widespread use of PD‐1 inhibitors to treat various solid tumors has brought certain challenges for the clinician, including immune‐related adverse events (irAEs). Cutaneous toxicities are among the most observed irAEs. Bullous and lichenoid dermatoses following PD‐1 inhibitor therapy have been d...
Autores principales: | Shah, Rohan R., Bhate, Chinmoy, Hernandez, Amanda, Ho, Chin Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286841/ https://www.ncbi.nlm.nih.gov/pubmed/35266258 http://dx.doi.org/10.1111/dth.15432 |
Ejemplares similares
-
Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022) -
Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering
por: Hübner, Franziska, et al.
Publicado: (2019) -
Non-bullous Lichen Planus Pemphigoides: A Case Report
por: LAMBERTS, Aniek, et al.
Publicado: (2020) -
Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab
por: Olsen, Eric, et al.
Publicado: (2023) -
Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab
por: Li, Si-Zhe, et al.
Publicado: (2022)